MOMETASON Mepha spray nasal 50 mcg 3 x 140 dos
7680632480024
CH-63248
R01AD09
12.02.3.
1 / 3
google
Details
- Product number
- 6324801
- CPT
- -
- Packaging group
- 3 x 140
- Unit
- Einzeldose(n)
- Composition
- mometasoni-17 furoas 50 µg ut mometasoni-17 furoas monohydricus, cellulosum microcristallinum et carmellosum natricum, glycerolum, polysorbatum 80, acidum citricum monohydricum, natrii citras dihydricus, benzalkonii chloridum 20 µg, aqua ad iniectabile, ad suspensionem pro dosi, doses pro vase 140.
Articles (1)
Mometason-Mepha Nasenspray, Suspension
suspension
3 x 140
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
50.0 UG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
20.0 UG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 37.85
Specialties list
Yes
Generic
Yes
SL addition date:
01/11/2017
Authorization holder
Mepha Pharma AG
4051 Basel
Authorization information
- Swissmedic authorization number
- 63248
- Drug name
- Mometason-Mepha Nasenspray, Suspension
- Galenic form
- NASSS
- ATC Code
- R01AD09
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 07/02/2014
- Authorization expiration date
- 31/12/9999
- IT number
- 12.02.3.
- Domain
- Human medicine
Packaging details
- Description (FR)
- MOMETASON Mepha spray nasal 50 mcg 3 x 140 dos
- Description (DE)
- MOMETASON Mepha Nasenspray 50 mcg 3 x 140 Dos
- Market launch
- 07/02/2014
- Narcotic (BTM)
- No